SCHEMBL6845394

SCHEMBL6845394

C[C](C)c1ccc(CCNC(C)=O)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.70
F13A1 P00488 1/20 0.70
SMN1; SMN2 Q16637 1/20 0.64
ALDH1A1 P00352 3/20 0.59
MAPT P10636 2/20 0.59
LMNA P02545 1/20 0.59
HPGD P15428 1/20 0.59
PTGS1 P23219 1/20 0.59
BLM P54132 1/20 0.59
HIF1A Q16665 1/20 0.59
HSD17B10 Q99714 1/20 0.59
HDAC3 O15379 1/20 0.55
HDAC4 P56524 1/20 0.55
HDAC1 Q13547 1/20 0.55
HDAC7 Q8WUI4 1/20 0.55
HDAC2 Q92769 1/20 0.55
HDAC10 Q969S8 1/20 0.55
HDAC11 Q96DB2 1/20 0.55
HDAC8 Q9BY41 1/20 0.55
HDAC6 Q9UBN7 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10592850 0.90 KDM4E (0.84) KDM4EF13A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL3203944 0.89 KDM4E (0.70) KDM4EF13A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL6329536 0.89 KDM4E (0.70) KDM4EF13A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL3523937 0.87 KDM4E (0.68) KDM4EF13A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL4864495 0.85 KDM4E (0.66) KDM4EF13A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL14966449 0.84 SMN1; SMN2 (0.68) KDM4EF13A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL16017577 0.84 PLK1 (0.64) KDM4EF13A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL10451965 0.84 KDM4E (0.64) KDM4EF13A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL4867311 0.84 ALDH1A1 (0.73) KDM4EF13A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL11553305 0.82 KDM4E (0.72) KDM4EF13A1SMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6770650-B2 CHEMOKINE RECEPTOR (CCR) ANTAGONISTS SUCH AS N-(1(S)-(4-(3,4-DICHLOROBENZYL)PIPERAZIN-1-YLMETHYL)-2-METHYLPROPYL)-4 -METHYLBENZAMIDE DIHYDROCHLORIDE SALT FOR TREATMENT OF ASTHMA SYNTEX (U.S.A.) LLC 2004-08-03 US disclosed
US-6323223-B1 CCR-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, METHODS FOR THEIR USE AND METHODS FOR PREPARING THESE COMPOUNDS. SYNTEX (U.S.A.) LLC 2001-11-27 US disclosed